Cargando…
Targeting Thyrointegrin αvβ3 Using Fluorobenzyl Polyethylene Glycol Conjugated Tetraiodothyroacetic Acid (NP751) in Acute Myeloid Leukemia
BACKGROUND: Acute myeloid leukemia (AML) is associated with poor long-term survival, even with newer therapeutic agents. Here, we show the results of our preclinical study, in which we evaluated the efficacy of a new thyrointegrin αvβ3 antagonist, named fluorobenzyl polyethylene glycol conjugated te...
Autores principales: | Darwish, Noureldien H. E., Glinsky, Gennadi V., Sudha, Thangirala, Mousa, Shaker A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828484/ https://www.ncbi.nlm.nih.gov/pubmed/35155195 http://dx.doi.org/10.3389/fonc.2021.793810 |
Ejemplares similares
-
Pharmacokinetics of fluorobenzyl polyethylene glycol conjugated tetraiodothyroacetic acid (NP751), a novel anticancer thyrointegrin α(v)β(3) antagonist
por: Fujioka, Kazutoshi, et al.
Publicado: (2022) -
Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin α(v)β(3) Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer
por: Sudha, Thangirala, et al.
Publicado: (2022) -
Novel Polyethylene Glycol-Conjugated Triazole Derivative with High Thyrointegrin αvβ3 Affinity in Acute Myeloid Leukemia Management
por: Sudha, Thangirala, et al.
Publicado: (2021) -
Discovery of novel thyrointegrin αvβ3 antagonist fb-PMT (NP751) in the management of human glioblastoma multiforme
por: Godugu, Kavitha, et al.
Publicado: (2022) -
Anti-Cancer Activities of Thyrointegrin α(v)β(3) Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma
por: Godugu, Kavitha, et al.
Publicado: (2021)